Robert Wheeler
Critical Care Medicine · Lima, OHNPI 1659365740
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,229 of the $2,555 with a category attached, or 87.2%. It is spread thinly across 35 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations.
Across 134 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$300
- Boehringer Ingelheim$224
- Novo Nordisk$146
- AbbVie$146
- Indivior Inc.$139
- Gilead$136
- plus $1K from 29 others
What the payments were for
- Speaking & faculty fees$30012%
- Food & beverage$2,22987%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 1 | $300 |
| Boehringer Ingelheim | 12 | $224 |
| Novo Nordisk | 11 | $146 |
| AbbVie | 10 | $146 |
| Indivior Inc. | 5 | $139 |
| Gilead | 9 | $136 |
| AstraZeneca | 2 | $125 |
| Johnson & Johnson | 7 | $102 |
| Novartis | 7 | $102 |
| Merck | 6 | $96 |
| Sunovion Pharmaceuticals Inc. | 5 | $95 |
| Pear Therapeutics (US), Inc. | 5 | $94 |
| Lilly USA, LLC | 6 | $89 |
| Alkermes, Inc. | 5 | $84 |
| Sanofi-aventis U.S. LLC | 5 | $82 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $75 |
| Zealand Pharma US, Inc. | 4 | $68 |
| Biohaven Pharmaceuticals, Inc. | 3 | $52 |
| Pfizer | 3 | $50 |
| Astellas Pharma US Inc | 2 | $43 |
| Amgen | 3 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Abbott | 2 | $30 |
| Valeritas, Inc. | 2 | $28 |
| IBSA Pharma Inc. | 2 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Insulet Corporation | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Lifescan, Inc. | 1 | $14 |
| Biogen | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Bayer | 1 | $12 |
| Dexcom, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,555 in reported general payments places this provider in the 85th percentile of 285 critical care medicine providers in Ohio.
Other critical care medicine in Lima
- Seth SklareLima$2K
- Neal ChaissonCleveland$428K
- Robert SchilzCleveland$356K
- Nicholas PastisColumbus$145K
- Michael EssandohColumbus$135K
- Chiedozie UdehCleveland$24K
- Kari GorderColumbus$20K
- Elliott CrouserColumbus$16K
- Sadia BenzaquenCincinnati$15K
- Lawrence GoldsteinBoardman$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.